ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 68 filers reported holding ACCELERATE DIAGNOSTICS INC in Q1 2023. The put-call ratio across all filers is 3.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $25,487 | -53.7% | 36,100 | 0.0% | 0.00% | -66.7% |
| Q3 2022 | $55,000 | +52.8% | 36,100 | 0.0% | 0.00% | +200.0% |
| Q2 2022 | $36,000 | -30.8% | 36,100 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $52,000 | -72.3% | 36,100 | 0.0% | 0.00% | -71.4% |
| Q4 2021 | $188,000 | -10.5% | 36,100 | 0.0% | 0.01% | -22.2% |
| Q3 2021 | $210,000 | -27.8% | 36,100 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $291,000 | -3.0% | 36,100 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $300,000 | +9.5% | 36,100 | 0.0% | 0.01% | +9.1% |
| Q4 2020 | $274,000 | -28.8% | 36,100 | 0.0% | 0.01% | -38.9% |
| Q3 2020 | $385,000 | -29.6% | 36,100 | 0.0% | 0.02% | -41.9% |
| Q2 2020 | $547,000 | +173.5% | 36,100 | +50.4% | 0.03% | +93.8% |
| Q1 2020 | $200,000 | -78.9% | 24,000 | -57.2% | 0.02% | -69.2% |
| Q4 2019 | $948,000 | +170.1% | 56,064 | +235.7% | 0.05% | +147.6% |
| Q1 2019 | $351,000 | +81.9% | 16,700 | 0.0% | 0.02% | +61.5% |
| Q4 2018 | $193,000 | – | 16,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 4,387,590 | $46,772,000 | 15.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 4,091,749 | $43,618,000 | 5.75% |
| GRIFFIN ASSET MANAGEMENT, INC. | 1,439,613 | $15,346,000 | 2.36% |
| Selkirk Management LLC | 348,805 | $3,718,000 | 1.18% |
| Chicago Capital, LLC | 1,966,891 | $20,967,000 | 1.08% |
| Trellus Management Company, LLC | 46,834 | $499,000 | 0.51% |
| Cannell & Co. | 1,118,439 | $11,923,000 | 0.44% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 155,000 | $1,652,000 | 0.36% |
| Belpointe Asset Management LLC | 419,406 | $3,982,000 | 0.27% |
| TCI Wealth Advisors, Inc. | 55,586 | $593,000 | 0.23% |